Menopause is not a niche subject. It actually affects 1% of women before the age of 40, and the perimenopausal period (transition to menopause) can last up to 8 years. That can mean years of debilitating symptoms and hormonal fluctuations that, without the proper management, can lead to serious long-term health conditions.
In this engaging discussion on World Menopause Day, Hertility CEO and Founder, Dr Helen O’Neill (MSc, PhD), and Dr Vikram Talaulikar (MBBS, MD, MRCOG, PhD), cover everything you need to know about menopause and how to manage it, including:
What is menopause & the menopausal transition
Different types of HRT
The Controversies of HRT
Non-hormonal methods of managing menopause symptoms
A sneak peak into Hertility’s new Menopause Monit-HER Test
About our guest expert, Dr Vikram Talaulikar (MBBS, MD, MRCOG, PhD)
Dr Vikram Talaulikar is a Specialist in Reproductive Medicine at University College London Hospitals NHS Foundation Trust and Hon. Associate Professor in Women’s Health at the University College London. He graduated in medicine in India in 2003 and completed a postgraduate degree in obstetrics and gynaecology in 2007.
He is a fellow of the Royal College of Obstetricians and Gynaecologists and completed a PhD degree at St. George’s University of London in 2016. His clinical interests include reproductive endocrinology, polycystic ovary syndrome, recurrent miscarriage, premature ovarian insufficiency, and Menopause.
He is a certified ‘menopause specialist’ by the British Menopause Society. He has published widely in Reproductive Medicine and Menopause. He is a member of the British Fertility Society, European Society of Human Reproduction and Embryology, British Menopause Society, and International Menopause Society.
He runs a busy menopause and PCOS clinic at UCLH and Menopause Clinic London on Harley Street. He is a Principal trainer for FSRH Menopause SS module and a trainer for BMS principles and practice of menopause care programme.
About our Speaker, Dr Helen O'Neill (MSc, PhD)
Dr Helen is a lecturer in reproductive and molecular genetics and a leading expert in reproductive science. She has a Masters in Prenatal Genetics and Fetal Medicine and a PhD in Stem Cell Biology from UCL. Her research focuses on pre-implantation embryo development and the use of CRISPR genome editing to assess understanding and treatment of disorders of infertility.
She was awarded the Top Twenty Women in Data in 2019 and one of the Top Fifty Inspirational Women in Technology in 2022. She is also a Lecturer at University College London, where she lectures both masters and medical students in reproductive and molecular genetics and is a thought leader in reproductive science, speaking at various conferences and TedX events.
About Hertility
Hertility is a digital health company shaping the future of reproductive healthcare. We’re working with the world’s most forward-thinking companies to proactively support employees across every life stage with end-to-end care spanning women’s health, men’s health, fertility & family-forming & menopause.
The workplace wasn’t designed with women in mind, we’re here to change that. We support employers to attract, support and retain a diverse, thriving and innovative workforce with expert-led CPD-accredited educational workshops, comprehensive at-home testing, telemedicine and treatment and workplace infrastructure and policy review.
We’ve spent years becoming the most regulated at-home reproductive care provider, including being fully CQC-approved, MHRA-regulated and CE-marked, and we’re committed to providing the highest quality service complete with a clinical care team with unparalleled education and training and a vetted network of partner clinics for further specialist treatment.
Информация по комментариям в разработке